837
Views
0
CrossRef citations to date
0
Altmetric
Brief Report

High plasma soluble CLEC-2 level predicts oxygen therapy requirement in patients with COVID-19

, , , , , , , , & show all
Article: 2244594 | Received 31 Dec 2022, Accepted 28 Jul 2023, Published online: 14 Aug 2023

References

  • Rubino S, Kelvin N, Bermejo-Martin JF, Kelvin DJ. As COVID-19 cases, deaths and fatality rates surge in Italy, underlying causes require investigation. J Infect Dev Ctries. 2020;14(3):265–6. doi:10.3855/jidc.12734.
  • Banerjee A, Chen S, Pasea L, Lai AG, Katsoulis M, Denaxas S, Nafilyan V, Williams B, Wong WK, Bakhai A, et al. Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic. Eur J Prev Cardiol. 2021;28(14):1599–609. doi:10.1093/eurjpc/zwaa155.
  • Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62. doi:10.1016/S0140-6736(20)30566-3.
  • Fahmy OH, Daas FM, Salunkhe V, Petrey JL, Cosar EF, Ramirez J, Akca O. Is microthrombosis the main pathology in coronavirus disease 2019 severity?—A systematic review of the postmortem pathologic findings. Crit Care Explor. 2021;3(5):e0427. doi:10.1097/cce.0000000000000427.
  • Conway EM, Mackman N, Warren RQ, Wolberg AS, Mosnier LO, Campbell RA, Gralinski LE, Rondina MT, van de Veerdonk FL, Hoffmeister KM, et al. Understanding COVID-19-associated coagulopathy. Nat Rev Immunol. 2022;22(October):639–49. doi:10.1038/s41577-022-00762-9.
  • Zaid Y, Puhm F, Allaeys I, Naya A, Oudghiri M, Khalki L, Limami Y, Zaid N, Sadki K, Ben El Haj R, et al. Platelets can associate with SARS-CoV-2 RNA and are hyperactivated in COVID-19. Circ Res. 2020;1404–1418. doi:10.1161/CIRCRESAHA.120.317703.
  • Suzuki-Inoue K, Fuller GLJ, García Á, Eble JA, Pöhlmann S, Inoue O, Gartner TK, Hughan SC, Pearce AC, Laing GD, et al. Anovel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood. 2006;107(2):542–9. doi: 10.1182/blood-2005-05-1994.
  • Kazama F, Nakamura J, Osada M, Inoue O, Oosawa M, Tamura S, Tsukiji N, Aida K, Kawaguchi A, Takizawa S, et al. Measurement of soluble C-type lectin-like receptor 2 in human plasma. Platelets. 2015;26(8):711–9. doi:10.3109/09537104.2015.1021319.
  • Yamashita Y, Suzuki K, Mastumoto T, Ikejiri M, Ohishi K, Katayama N, Suzuki-Inoue K, Wada H. Elevated plasma levels of soluble C-type lectin-like receptor 2 (CLEC2) in patients with thrombotic microangiopathy. Thromb Res. 2019;178(November 2018):54–8. doi:10.1016/j.thromres.2019.03.018.
  • Sasaki T, Inoue O, Ogihara S, Kubokawa K, Oishi S, Shirai T, Iwabuchi K, Suzuki-Inoue K. Detection of SARS-CoV-2 RNA using RT-Qpcr in nasopharyngeal swab, saliva, lingual, and buccal mucosal swab. Jpn J Infect Dis. 2021;75(1):102–4. doi:10.7883/yoken.JJID.2021.091.
  • Yamamoto A, Wada H, Ichkawa Y, Tanaka M, Tashiro H, Shiraki K, Shimpo H, Yamashita Y, Mastumoto T, Shimaoka M, et al. Soluble C-type lectin-like receptor 2 is a biomarker for disseminated intravascular coagulation. J Clin Med. 2021;10(13):2860. doi: 10.3390/jcm10132860.
  • Malik P, Patel U, Mehta D, Patel N, Kelkar R, Akrmah M, Gabrilove JL, Sacks H. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis. BMJ Evidence-Based Med. 2021;26(3):107–8. doi:10.1136/bmjebm-2020-111536.
  • Prattichizzo F, de Candia P, Nicolucci A, Ceriello A. Elevated HbA1c levels in pre-Covid-19 infection increases the risk of mortality: A systematic review and meta-analysis. Diabetes Metab Res Rev. 2022;38(1):1–8. doi:10.1002/dmrr.3476.
  • Suzuki‐Inoue K, Inoue O, Ozaki Y. Novel platelet activation receptor CLEC‐2: from discovery to prospects. J Thromb Haemost . 2011;9:44–55. doi:10.1111/j.1538-7836.2011.04335.x.
  • Suzuki-Inoue K, Inoue O, Ding G, Nishimura S, Hokamura K, Eto K, Kashiwagi H, Tomiyama Y, Yatomi Y, Umemura K, et al. Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets. J Biol Chem . 2010;285(32):24494–507. doi:10.1074/jbc.M110.130575.
  • Shirai T, Inoue O, Tamura S, Tsukiji N, Sasaki T, Endo H, Satoh K, Osada M, Sato-Uchida H, Fujii H, et al. C-type lectin-like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor-bearing mice. J Thromb Haemost. 2017;15(3):513–25. doi:10.1111/jth.13604.
  • Wada H, Ichikawa Y, Ezaki M, Yamamoto A, Tomida M, Yoshida M, Fukui S, Moritani I, Shiraki K, Shimaoka M, et al. Elevated plasma soluble C-Type lectin-like receptor 2 is associated with the worsening of coronavirus disease 2019. J Clin Med. 2022;11(4):3–11. doi:10.3390/jcm11040985.
  • Paranjape N, Staples LL, Stradwick CY, Ray HG, Saldanha IJ. Development and validation of a predictive model for critical illness in adult patients requiring hospitalization for COVID-19. PLoS One . 2021;16(3 March):1–0. doi:10.1371/journal.pone.0248891.
  • Lee EE, Hwang W, Song KH, Jung J, Kang CK, Kim JH, Oh HS, Kang YM, Lee EB, Chin BS, et al. Predication of oxygen requirement in COVID-19 patients using dynamic change of inflammatory markers: CRP, hypertension, age, neutrophil and lymphocyte (CHANeL). Sci Rep. 2021;11(1):1–8. doi:10.1038/s41598-021-92418-2.
  • Hariri LP, North CM, Shih AR, Israel RA, Maley JH, Villalba JA, Vinarsky V, Rubin J, Okin DA, Sclafani A, et al. Lung histopathology in coronavirus disease 2019 as compared with severe acute respiratory syndrome and H1N1 influenza: a systematic review. Chest. 2021;159(1):73–84. doi:10.1016/j.chest.2020.09.259.
  • Dhont S, Derom E, Van Braeckel E, Depuydt P, Lambrecht BN. Conceptions of the pathophysiology of happy hypoxemia in COVID-19. Respir Res. 2021;22(1):1–9. doi:10.1186/s12931-021-01614-1.
  • Nicolai L, Leunig A, Brambs S, Kaiser R, Weinberger T, Weigand M, Muenchhoff M, Hellmuth JC, Ledderose S, Schulz H, et al. Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy. Circulation. 2020;142(12):1176–89. doi:10.1161/CIRCULATIONAHA.120.048488.
  • Martinod K, Deppermann C. Immunothrombosis and thromboinflammation in host defense and disease. Platelets. 2021;32(3):314–24. doi:10.1080/09537104.2020.1817360.
  • Semeraro F, Ammollo CT, Morrissey JH, Dale GL, Friese P, Esmon NL, Esmon CT. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood. 2011;118(7):1952–61. doi:10.1182/blood-2011-03-343061.
  • Inoue O, Osada M, Nakamura J, Kazama F, Shirai T, Tsukiji N, Sasaki T, Yokomichi H, Dohi T, Kaneko M, et al. Soluble CLEC-2 is generated independently of ADAM10 and is increased in plasma in acute coronary syndrome: comparison with soluble GPVI. Int J Hematol. 2019;110(3):285–94. doi:10.1007/s12185-019-02680-4.
  • Stenberg PE, McEver RP, Shuman MA, Jacques YV, Bainton DF. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol. 1985;101(3):880–6. doi:10.1083/jcb.101.3.880.
  • Zuo Y, Yalavarthi S, Shi H, Gockman K, Zuo M, Madison JA, Blair CN, Weber A, Barnes BJ, Egeblad M, et al. Neutrophil extracellular traps in COVID-19. JCI Insight. 2020; doi:10.1172/jci.insight.138999.